CN115212357A - 一种可降解抗菌防结石支架管及其应用 - Google Patents
一种可降解抗菌防结石支架管及其应用 Download PDFInfo
- Publication number
- CN115212357A CN115212357A CN202111160859.5A CN202111160859A CN115212357A CN 115212357 A CN115212357 A CN 115212357A CN 202111160859 A CN202111160859 A CN 202111160859A CN 115212357 A CN115212357 A CN 115212357A
- Authority
- CN
- China
- Prior art keywords
- stent tube
- polylactic acid
- anticalculus
- base material
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 43
- 230000002272 anti-calculus Effects 0.000 title claims abstract description 25
- 229920001661 Chitosan Polymers 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 35
- 230000004048 modification Effects 0.000 claims abstract description 19
- 238000012986 modification Methods 0.000 claims abstract description 19
- 229920003232 aliphatic polyester Polymers 0.000 claims abstract description 16
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 15
- 239000002131 composite material Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 46
- 239000004626 polylactic acid Substances 0.000 claims description 46
- 238000001035 drying Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229920000954 Polyglycolide Polymers 0.000 claims description 7
- -1 polytrimethylene carbonate Polymers 0.000 claims description 7
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 abstract description 22
- 210000002700 urine Anatomy 0.000 abstract description 8
- 239000012634 fragment Substances 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 5
- 206010046406 Ureteric obstruction Diseases 0.000 abstract description 2
- 230000008021 deposition Effects 0.000 abstract description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 239000002585 base Substances 0.000 description 22
- 230000015556 catabolic process Effects 0.000 description 17
- 239000000835 fiber Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 239000004744 fabric Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- CYZBTLOUSPYJHS-UHFFFAOYSA-M ethyl-bis(2-hydroxyethyl)-(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].OCC[N+](CC)(CCO)CC1CO1 CYZBTLOUSPYJHS-UHFFFAOYSA-M 0.000 description 8
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 8
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 8
- 210000000626 ureter Anatomy 0.000 description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 7
- 229940072056 alginate Drugs 0.000 description 7
- 235000010443 alginic acid Nutrition 0.000 description 7
- 229920000615 alginic acid Polymers 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 235000010413 sodium alginate Nutrition 0.000 description 6
- 239000000661 sodium alginate Substances 0.000 description 6
- 229940005550 sodium alginate Drugs 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000002074 melt spinning Methods 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 239000012265 solid product Substances 0.000 description 4
- 230000008093 supporting effect Effects 0.000 description 4
- 238000009954 braiding Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 208000004608 Ureteral Obstruction Diseases 0.000 description 2
- 238000003889 chemical engineering Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000031868 Calculus ureteric Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000000014 Ureteral Calculi Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/01—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with natural macromolecular compounds or derivatives thereof
- D06M15/03—Polysaccharides or derivatives thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/06—Coatings containing a mixture of two or more compounds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Textile Engineering (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
降解时间/天 | 机械性能 | 抗菌率% | |
实施例1 | 合格 | 优 | 94.1 |
实施例2 | 合格 | 优 | 92.3 |
对比例1 | 不合格 | 良 | 86.7 |
对比例2 | 不合格 | 差 | 88.4 |
对比例3 | 不合格 | 良 | 90.6 |
对比例4 | 不合格 | 良 | 89.2 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111160859.5A CN115212357B (zh) | 2021-09-30 | 2021-09-30 | 一种可降解抗菌防结石支架管及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111160859.5A CN115212357B (zh) | 2021-09-30 | 2021-09-30 | 一种可降解抗菌防结石支架管及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115212357A true CN115212357A (zh) | 2022-10-21 |
CN115212357B CN115212357B (zh) | 2024-02-20 |
Family
ID=83605927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111160859.5A Active CN115212357B (zh) | 2021-09-30 | 2021-09-30 | 一种可降解抗菌防结石支架管及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115212357B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1442458A (zh) * | 2003-04-03 | 2003-09-17 | 复旦大学 | 一种用于医疗器械的亲水润滑涂层及其涂覆方法 |
WO2004075798A1 (en) * | 2003-02-28 | 2004-09-10 | Sca Hygiene Products Ab | Method of producing an absorbent article and an absorbent article produced according to the method |
EP2194960A1 (en) * | 2007-09-07 | 2010-06-16 | Cutech S.R.L. | Compositions comprising ornithine ketoglutarate (okg) |
CN101987050A (zh) * | 2009-08-06 | 2011-03-23 | 浙江普洛医药科技有限公司 | 可降解双层复合输尿管支架管 |
CN104043152A (zh) * | 2014-06-23 | 2014-09-17 | 林涵 | 镇痛抗菌亲水润滑乳胶医用导管及其制备方法 |
US20140301955A1 (en) * | 2006-06-02 | 2014-10-09 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
CN109758620A (zh) * | 2019-03-12 | 2019-05-17 | 东华大学 | 一种长效抗菌可降解的输尿管支架管及其制备方法 |
CN112915265A (zh) * | 2021-04-29 | 2021-06-08 | 天津百和至远医疗技术有限公司 | 一种亲水抗菌可降解的输尿管支架管及其制备方法 |
CN113663142A (zh) * | 2021-09-03 | 2021-11-19 | 中国科学院长春应用化学研究所 | 一种适用于泌尿类医疗器械的多功能性涂层、其制备方法及其应用 |
-
2021
- 2021-09-30 CN CN202111160859.5A patent/CN115212357B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004075798A1 (en) * | 2003-02-28 | 2004-09-10 | Sca Hygiene Products Ab | Method of producing an absorbent article and an absorbent article produced according to the method |
CN1442458A (zh) * | 2003-04-03 | 2003-09-17 | 复旦大学 | 一种用于医疗器械的亲水润滑涂层及其涂覆方法 |
US20140301955A1 (en) * | 2006-06-02 | 2014-10-09 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
EP2194960A1 (en) * | 2007-09-07 | 2010-06-16 | Cutech S.R.L. | Compositions comprising ornithine ketoglutarate (okg) |
CN101987050A (zh) * | 2009-08-06 | 2011-03-23 | 浙江普洛医药科技有限公司 | 可降解双层复合输尿管支架管 |
CN104043152A (zh) * | 2014-06-23 | 2014-09-17 | 林涵 | 镇痛抗菌亲水润滑乳胶医用导管及其制备方法 |
CN109758620A (zh) * | 2019-03-12 | 2019-05-17 | 东华大学 | 一种长效抗菌可降解的输尿管支架管及其制备方法 |
CN112915265A (zh) * | 2021-04-29 | 2021-06-08 | 天津百和至远医疗技术有限公司 | 一种亲水抗菌可降解的输尿管支架管及其制备方法 |
CN113663142A (zh) * | 2021-09-03 | 2021-11-19 | 中国科学院长春应用化学研究所 | 一种适用于泌尿类医疗器械的多功能性涂层、其制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN115212357B (zh) | 2024-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gatenholm et al. | Bacterial nanocellulose as a renewable material for biomedical applications | |
Klemm et al. | Nanocellulose materials–different cellulose, different functionality | |
JP5620082B2 (ja) | 生体吸収性縫合糸 | |
CN104174065B (zh) | 一种可吸收人工血管及其制备方法和应用 | |
CN104353128A (zh) | 一种可降解血管支架及其制备方法和应用 | |
de la Harpe et al. | Advances in carbohydrate-based polymers for the design of suture materials: a review | |
CN112516372A (zh) | 一种用于可吸收手术缝合线的复合载药纤维 | |
CN115025294B (zh) | 一种可降解封堵器的促内皮化表面改性方法及其制备的改性可降解封堵器 | |
CN110354298B (zh) | 一种原位交联银纳米线/聚己内酯手术缝合线的制备方法 | |
CN105056295B (zh) | 一种抗炎抗菌可吸收医用缝合线及其制备方法 | |
CN104225690A (zh) | 一种可吸收骨折内固定材料及其制备方法和应用 | |
CN106535947A (zh) | 伤口敷料 | |
RU2585576C1 (ru) | Способ получения биодеградируемого полимерного покрытия с контролируемым выходом лекарственного средства для малоинвазивной хирургии | |
CN115212357A (zh) | 一种可降解抗菌防结石支架管及其应用 | |
CN107754016A (zh) | 一种用于心脏组织工程的聚乳酸/壳聚糖复合纳米纤维支架的制备方法 | |
Pillai et al. | Chitosan: manufacture, properties and uses | |
CN111760065A (zh) | 一种高强度高抗菌性可吸收缝合线 | |
WO2017028626A1 (zh) | 一种可吸收手术缝合线及其制备方法 | |
CN105079875A (zh) | 一种胸膜/脑膜及其制备方法 | |
CN211096500U (zh) | 一种即时穿刺透析型纳米纤维人工血管 | |
US20230218379A1 (en) | An auxetic structure, a support structure, a method of preparing an auxetic structure, and use of a cellulosic material | |
US10624989B2 (en) | Implant comprising oxidized cellulose and method for preparing such an implant | |
EP2875834A1 (en) | Medical devices and methods of manufacture thereof | |
CN114059350A (zh) | 一种天然长效抗菌抗炎蚕丝缝合线及其制备方法 | |
CN107296980B (zh) | 一种pfb水响应形状记忆组织工程支架及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240510 Address after: No. 185 Pu'an Road, Huangpu District, Shanghai, 200000 Patentee after: SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI University OF TRADITIONAL CHINESE MEDICINE Country or region after: China Address before: 331800 Room 401, Unit 1, Building 3, No. 125, Heng'an East Road, Production Street, Xiaogang Town, Dongxiang District, Fuzhou City, Jiangxi Province Patentee before: Ju Guanqun Country or region before: China |